Non Compaction Cardiomyopathy Masquerading as Asthma: A Case Report

Left ventricular non-compaction (LVNC) is a rare form of cardiomyopathy, which leads to progressive heart failure, arrhythmias, and thromboembolic events. Due to variable clinical presentations, it is often misdiagnosed as another cardiomyopathy or asthma. Here we report a case of 50 year-old-male who had multiple emergency room visits for shortness of breath (SOB) which were treated acutely with bronchodilators for presumptive asthma exacerbations. Subsequently, a 2D, color flow transthoracic echocardiogram was performed, which revealed the presence of dilated cardiomyopathy, and a low LV ejection fraction. In addition, left ventricular trabeculation was greater than that anticipated, with prominent inter trabecular recesses, supporting the diagnosis of LVNC. A family history of early onset heart failure was present. This case is presented to help physicians consider non-compaction cardiomyopathy as an etiology in patients who present with SOB and low ejection fraction (EF).


Introduction
Non-compaction of the left ventricle is a congenital abnormality, occurring between 5 to 8 weeks of life, in which the myocardium fails to transform into compact. As a result the cardiac muscle takes a spongiform appearance with hypertrabeculation and deep recesses in the ventricular wall [1]. Left untreated, this defect in endomyocardial morphogenesis can result in a dilated cardiomyopathy & severe systolic dysfunction [2]. Several genetic mutations have been identified including defects in the genes coding for α-dystrobrevin, LIM domain binding protein 3, tropomyosin, tafazzin, , α-cardiac actin etc. [3,4]. Due to recent advance in diagnostic imaging, the incidence has increased with current incidence of 3-4 % in heart failure patients [5]. Non-compaction cardiomyopathy is usually diagnosed at a young age; however a few cases have been reported in an older age group [3]. The clinical presentation varies from asymptomatic to arrhythmia, heart failure, and systemic embolism. Here we present a case of a middle-aged African-American male presenting with dyspnea, treated as asthma exacerbation, but diagnosed with non-compaction cardiomyopathy and heart failure after echocardiographic evaluation.

Case Presentation
A 50-year-old African-American male with past medical history of asthma presented with shortness of breath (SOB) for 4 weeks. He reported progressive dyspnea for a few days prior to admission, especially walking 20 steps, climbing stairs, and at night. Bilateral lower extremity edema was present, but he denied any chest pain, palpitation, dizziness, wheezing, or cough. There was no history of hypertension, diabetes, coronary artery disease, recent febrile illness, or illicit drug use. The patient had similar episodes in the past, and was treated for asthma with albuterol with subsequent improvement. During the current episode, the patient attempted to use albuterol with little improvement of his symptoms. The patient was a non-smoker, and his family history was notable for a twin brother who recently had been diagnosed with congestive heart failure (CHF).
Transthoracic echocardiography revealed a dilated left ventricle with EF of 10-15% and false tendon in the left ventricle with prominent trabeculations along the apical and lateral walls, with multiple intertrabecular recesses suggestive of left ventricular (LV) non-compaction (Figure 1, Figure 2A and Figure 2B). End systolic ratio of non-compacted to compacted layer was ≥2. Left atrium was dilated and mitral and tricuspid valve showed mild to moderate regurgitation without any stenosis. The patient was advised to have cardiac catheterization, but he refused because of the possible procedural risks. A nuclear stress test was performed, and was negative for ischemia. He was counseled regarding the importance of medication compliance, and was discharged with a diuretic, β-blocker, and ACE inhibitor. At his follow-up appointment, a repeat echocardiogram showed EF of 20% and automatic Implantable cardioveter defibrillator (AICD) was placed by electrophysiologist.

Discussion
LVNC is an uncommon genetic cardiomyopathy with an estimated prevalanvce of 0.01 to 0.05 % in adults [2]. Because of its variable phenotypical and clinical presentation, it is often unrecognized and misdiagnosed as another cardiomyopathies or diseases [6,7]. The diagnosis typically requires genetic testing combined with various cardiac imaging modalities [3,6]. The echocardiogram is often suggestive, and key features of LVNC include: prominent LV trabeculum with deep intertrabecular recesses particularly in the apical and lateral walls; prominent color flow in the trabecular recesses; a double layer ventricular wall with an end systolic ratio of non compacted to compacted myocardium of > 2 [6,8,9]. These features help differentiate LVNC from hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy due to LVH. In addition, administration of IV contrast can increase the detection of trabeculae, trabecular recess and LV thrombi. Of note cardiac MRI offers better spatial resolution than echocardiogram and MRI based morphological features provide prognostic information with regard to recovery of LV systolic function and the incidence of tachyarrthymia [10]. The presence of late gadolinium enhancement on MRI associated with worse outcomes [10].
Clinically, the absence of ventricular myocardiac compaction is associated with CHF, arrhythmia, thromboembolism [11]. Prognosis depends on ratio of non compacted to compacted myocardium as well as the degree of the LV systolic dysfunction [11]. Current guidelines recommend standard therapy with combinations of B blockers, ACE/ ARBS, diuretics and aldosterone antagonists [12]. Anti coagulation is indicated in patients with a history of thromboembolism and may be considered in those with a dilated LV and LVEF < 40 %. The role of anticoagulation in preserved EF is controversial [13]. Since patients are at increased risk for sudden cardiac death (SCD), patients should be screened for the presence of ventricular arrthymias. Stanton et al [14] reported ventricular tachycardia in 27 % of LVNC on Holter monitoring. An AICD is indicated in patients with sustained ventricular tachycardia or those who have survived cardiac arrest. In all other patients with reduced EF prophylactic AICD may be considered (ACC/ AHA, class II b heart failure, 2012 guidelines on device heart therapy) [15]. Radio frequency ablation may be a treatment option [16]. Genetic testing for LVNC should be considered in family members and appropriate relatives following the identification of a LVNC causative mutation in the index case [17].

Conclusion
In conclusion, because it is often overlooked or misdiagnosed, left ventricular non compaction should be considered in patients with a family history of CHF who present with dyspnea and are subsequently found to have a dilated cardiomyopathy. Proper evaluation along with screening among family members may be the key to decreasing the morbidity and mortality of this congenital cardiomyopathy.